Mendell J - Search Results

1

A thorough QTc study demonstrates that olmesartan medoxomil does not prolong the QTc interval.

Mendell J, Matsushima N, O'Reilly TE, Lee J. Mendell J, et al. J Clin Pharmacol. 2016 Apr;56(4):484-91. doi: 10.1002/jcph.610. Epub 2015 Nov 9. J Clin Pharmacol. 2016. PMID: 26239632 Free PMC article. Clinical Trial.

2

Linear mixed-effects model of QTc prolongation for olmesartan medoxomil.

Song S, Matsushima N, Lee J, Mendell J. Song S, et al. Among authors: mendell j. J Clin Pharmacol. 2016 Jan;56(1):96-100. doi: 10.1002/jcph.572. Epub 2015 Aug 24. J Clin Pharmacol. 2016. PMID: 26096571 Free PMC article. Clinical Trial. No abstract available.

3

Edoxaban drug-drug interactions with ketoconazole, erythromycin, and cyclosporine.

Parasrampuria DA, Mendell J, Shi M, Matsushima N, Zahir H, Truitt K. Parasrampuria DA, et al. Among authors: mendell j. Br J Clin Pharmacol. 2016 Dec;82(6):1591-1600. doi: 10.1111/bcp.13092. Epub 2016 Sep 23. Br J Clin Pharmacol. 2016. PMID: 27530188 Free PMC article. Clinical Trial.

4

Population pharmacokinetic analysis of patritumab, a HER3 inhibitor, in subjects with advanced non-small cell lung cancer (NSCLC) or solid tumors.

Yoshiba S, Jansen M, Matsushima N, Chen S, Mendell J. Yoshiba S, et al. Among authors: mendell j. Cancer Chemother Pharmacol. 2016 May;77(5):987-96. doi: 10.1007/s00280-016-3011-0. Epub 2016 Mar 26. Cancer Chemother Pharmacol. 2016. PMID: 27017616

5

Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects.

Matsushima N, Lee F, Sato T, Weiss D, Mendell J. Matsushima N, et al. Among authors: mendell j. Clin Pharmacol Drug Dev. 2013 Oct;2(4):358-66. doi: 10.1002/cpdd.53. Epub 2013 Sep 9. Clin Pharmacol Drug Dev. 2013. PMID: 27121940

6

Edoxaban administration following enoxaparin: a pharmacodynamic, pharmacokinetic, and tolerability assessment in human subjects.

Zahir H, Matsushima N, Halim AB, He L, Zhang G, Lee F, Worland V, Mendell J. Zahir H, et al. Among authors: mendell j. Thromb Haemost. 2012 Jul;108(1):166-75. doi: 10.1160/TH11-09-0676. Epub 2012 May 25. Thromb Haemost. 2012. PMID: 22628060 Clinical Trial.

7

Drug-drug interaction studies of cardiovascular drugs involving P-glycoprotein, an efflux transporter, on the pharmacokinetics of edoxaban, an oral factor Xa inhibitor.

Mendell J, Zahir H, Matsushima N, Noveck R, Lee F, Chen S, Zhang G, Shi M. Mendell J, et al. Am J Cardiovasc Drugs. 2013 Oct;13(5):331-42. doi: 10.1007/s40256-013-0029-0. Am J Cardiovasc Drugs. 2013. PMID: 23784266 Free PMC article. Clinical Trial.

8

Randomized, Double-Blind, Single-Dose, Placebo-Controlled Crossover Study to Evaluate the Effects of Esaxerenone on QTc Interval in Healthy Subjects.

Mendell J, Kobayashi F, Shimizu T. Mendell J, et al. Clin Pharmacol Drug Dev. 2020 Aug;9(6):709-718. doi: 10.1002/cpdd.794. Epub 2020 Apr 7. Clin Pharmacol Drug Dev. 2020. PMID: 32255542 Clinical Trial.

9

A thorough electrocardiogram study of edoxaban, a novel factor Xa inhibitor.

Mendell J, Basavapathruni R, Swearingen D, Draves A, Zhang G, Morganroth J. Mendell J, et al. J Clin Pharmacol. 2011 Aug;51(8):1241-6. doi: 10.1177/0091270010381901. Epub 2011 Jan 5. J Clin Pharmacol. 2011. PMID: 21209229 Clinical Trial. No abstract available.

10

Abuse potential of mirogabalin in recreational polydrug users.

Mendell J, Levy-Cooperman N, Sellers E, Vince B, Kelsh D, Lee J, Warren V, Zahir H. Mendell J, et al. Ther Adv Drug Saf. 2019 Apr 5;10:2042098619836032. doi: 10.1177/2042098619836032. eCollection 2019. Ther Adv Drug Saf. 2019. PMID: 31057786 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

563 results

Search Page

Filters